Coverage Issues Manual
Section 45-30 Photosensitive Drugs, is revised to delete the code reference for photosensitive drugs in the CIM because it belongs in the claims processing instructions.
Section 45-32 Levocarnitine for Use in the Treatment of Carnitine Deficiency in ESRD Patients, implements the National Coverage Determination (NCD) for Levocarnitine for End Stage Renal Disease under §1862(a)(1)(A) of the Social Security Act.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: November 08, 2002
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.